GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we treat high blood sugar. These new drugs work by stimulating the body’s own GLP-1 process, which https://followbookmarks.com/story21818609/glp-1-a-significant-breakthrough-in-diabetes-management